Rajeshwar Motheram

USPTO Granted Patents = 14 (Patent Applications = 17)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Randolph, NJ (US) (2018)
Dayton, OH (US) (2021)
Dayton, NJ (US) (2010 - 2023)

Company Filing History:

7 out of 26

The Medicines Company

patents

7 out of 328

Chiesi Farmaceutici S.p.a.

patents

2 out of 36

Eagle Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383507 - Clevidipine nanoparticles and pharmaceutical compositions thereof (2025-08-12),

2. 11737989 - Clevidipine nanoparticles and pharmaceutical compositions thereof (2023-08-29),

3. 11103490 - Clevidipine emulsion formulations containing antimicrobial agents (2021-08-31),

4. 11058672 - Pharmaceutical compositions and methods for producing low impurity concentrations of the same (2021-07-13),

5. 10039780 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2018-08-07),

6. 10010537 - Clevidipine emulsion formulations containing antimicrobial agents (2018-07-03),

7. 9700575 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2017-07-11),

8. 9439921 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2016-09-13),

9. 9295687 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2016-03-29),

10. 8754125 - Antimicrobial preservation of propofol emulsions (2014-06-17),

11. 8658676 - Clevidipine emulsion formulations containing antimicrobial agents (2014-02-25),

12. 7985733 - Buffer-based method for preparing bivalirudin drug product (2011-07-26),

13. 7803762 - Ready-to-use bivalirudin compositions (2010-09-28),

14. 7713928 - Ready-to-use bivalirudin compositions (2010-05-11),

Title: Rajeshwar Motheram: Pioneering Innovations in Pharmaceutical Compositions

Introduction

Rajeshwar Motheram is a distinguished inventor based in Dayton, NJ, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 14 patents, he has demonstrated a keen ability to innovate and enhance drug formulations, particularly in the area of nanoparticle technology.

Latest Patents

Among his latest patents is a groundbreaking pharmaceutical composition that involves clevidipine nanoparticles. This composition provides a sterile, ready-to-use, physically stable, aqueous dispersion of nanoparticles that stabilizes clevidipine, preventing the formation of impurities. This innovation is particularly beneficial for parenteral administration, making it a significant advancement in pharmaceutical formulations.

Career Highlights

Rajeshwar has held pivotal roles in prominent companies such as The Medicines Company and Chiesi Farmaceutici S.p.a., where he has leveraged his expertise to drive innovation and improve therapeutic solutions. His experience in these organizations has allowed him to advance his research and contribute to the development of impactful pharmaceutical products.

Collaborations

Throughout his career, Rajeshwar has collaborated with notable colleagues, including Min Ding and Panna Dutta. These partnerships have been instrumental in fostering innovation and translating research into effective pharmaceutical applications.

Conclusion

Rajeshwar Motheram's prolific career in the pharmaceutical industry showcases his commitment to advancing medicine through innovative research and development. His patents, particularly related to clevidipine nanoparticles, highlight his role as a key player in enhancing drug stability and delivery methods, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.